The bill establishes a regulatory framework for the production and administration of psilocybin in Iowa, introducing a new section, 124F, which defines key terms such as "active psilocybin" and "qualified medical psilocybin provider." It allows for the recommendation, possession, and administration of psilocybin under specific guidelines and mandates the creation of a licensing board to oversee psilocybin production establishments and testing laboratories. The bill outlines strict operational requirements, including inventory control systems, security measures, and employee training, while also prohibiting advertising to the general public and restricting transportation to registered agents only.

Additionally, the legislation includes provisions for the registration and continuing education of qualified medical psilocybin providers, ensuring they meet specific training requirements before administering psilocybin. It establishes penalties for non-compliance, including the revocation of licenses and fines for unauthorized access to electronic systems. The bill also requires annual reporting to the General Assembly on psilocybin use statistics and tasks the Department of Health and Human Services with studying other psychedelic compounds for medical treatment, with findings due by January 1, 2026. Overall, the bill aims to create a controlled and safe environment for psilocybin use while ensuring regulatory oversight and public safety.

Statutes affected:
Introduced: 124.401
Reprinted: 124.401